News

uMotif to Showcase Modern eConsent and eCOA Platform to Bolster the Pivotal Patient-Site Relationship in Clinical Trials at Life Sciences Events
The Clinical Trial Patient Experience: Balancing Science, Technology, and Humanity
How to Evaluate an eCOA Vendor for Global Trials
BYOD vs. Provisioned Devices: Why Participant Choice Should Drive Your eCOA Strategy
Strengthen Participant-Site Readiness for Complex Rare Disease Trials
uMotif Chief Scientific Officer Florence Mowlem PhD Wins PCMG Outsourcing Trailblazer of the Year Award
Achieving Clinical Trial Success with Three Key Elements of eCOA User Acceptance Testing
Why are eCOA studies still so challenging? And, how can we make them better?
uMotif Announces Andrea Valente is Chief Executive Officer